While kisspeptin was initially shown to suppress metastasis in melanoma, subsequent studies have found that KISS-1/kisspeptin could boost metastasis in malignancies ranging from liver to breast cancer, suggesting a dual identity for kisspeptin in cancer (166). Here, KISS1 is linked to breast carcinoma.